SMOKING CESSATION
One of the most important factors in the management of patients with COPD is the cessation of cigarette smoking. Susceptible smokers who develop COPD have an increased rate of decline in lung function measured as FEVa (80 ml/yr) compared to nonsusceptible smokers and nonsmokers (30 ml/yr) (Fig. 19-2]. Following cessation of smoking, the rate of decline in the susceptible smoker is reduced to that in the nonsmoker (30 ml/yr).
- ASTHMA
- INFECTIVE ENDOCARDITIS
- Chronic Interstitial Nephritis
- Plain Radiographs and Barium Contrast Studies
- Aminoaciduria
- PERIPHERAL VENOUS DISEASE
- MEDICAL MANAGEMENT OF ANGINA
- CYSTIC FIBROSIS
- NORMAL INTESTINAL PHYSIOLOGY
- Complications of Dialysis
- Pulmonary Hemorrhagic Disorders
- CHRONIC RENAL FAILURE
- PROGNOSIS
- SPECIFIC MANIFESTATIONS OF RENAL DISEASE
- Pathogenic Mechanisms
- Studies of Pancreatic Structure and Function
- THE SLEEP APNEA SYNDROME
- PULMOIIARY FUNCTION EVALUATION
- VENTILATION
- Systemic Vasculitides
- Pulmonary System
- CAUSES OF PULMONARY HYPERTENSION
- Clinical Manifestations
- PHYSIOLOGY OF THE PULMONARY CIRCULATION
- AORTIC ARTERITIS
- VASCULAR DISEASE OF THE LIVER
- SPECIFIC CLINICAL DISORDERS
- Specific Etiologies
- Diagnosis
- Blood Chemistries
- Ultrasound and Computed Tomography
- CLINICAL PRESENTATION AND DIAGNOSIS
- NONOBSTRUCTIVE CAUSES OF ISCHEMIC HEART DISEASE
- Pathology
- LABORATORY TESTS TOR BILIRUBIN